Cardiovascular disorders are currently the leading cause of mortality worldwide. Maintenance of a healthy cardiovascular system is pivotal to longevity in addition to keeping a healthy mind and body. Cordis by Animis is the most potent cardiovascular support formula currently available on the market.
With the utilization of a synergistic blend of natural herbs formulated in Cordis, each ingredient potentiates the pharmacokinetic effects of the other. Making the therapeutic effect of the formula more potent than that obtained from any individual compound. Users of this powerful formula will experience a reduction in blood pressure, lipids, plaque buildup, and improved liver function.
Cordis Ingredient Breakdown:
Elevated levels of cholesterol and blood pressure are two major contributors of atherosclerosis and cardiovascular disease . Salviae Miltiorrhizae has been used in traditional chinese medicine, for more than a millennium, for the treatment of blood disorders. Major components of salviae miltiorrhizae, include salvianolic acid & tanshinoate. Salvianolic acid B and Tanshinoate II are considered the two active component known for the management of circulatory disorders . Salviae Miltiorrhizae extract has been shown to increase the export of total cholesterol and bile acid in the liver, while reducing LDL-cholesterol and increasing HDL-cholesterol in humans . Tanshinoate IIA is one of the many active components responsible for lowering LDL, threw its ability to inhibit LDL oxidation . Tanshinoate also acts to upregulate superoxide dismutase activity and eNOS phosphorylation, making it a powerful antioxidant and increaser of NO production . Tanshinone IIA is a potent cardioprotective compound, that is able to regulate various transcription factors, ion channels, kinases, growth factor, inflammatory mediators, and more . Acting to limit hypertrophy, improve heart function and strength by decreasing oxidative stress .
Salvianolic acid B protective therapeutic effects are due to its ability to act as a potent antioxidant/reactive oxygen species, anti-fibrotic agent, and an inhibitor of inflammation. Additionally, Salvianolic acid B is able to act as inhibitor of ACE, reducing the conversion of angiotensin I to angiotensin II and lowering blood pressure . Tanshinoate IIA like Salvianolic acid B is able to indirectly reduce the production of angiotensin II. In addition Tanshinoate IIA is able to reduce the accumulation of cholesterol by macrophages, vary smooth muscle migration and proliferation. As well as reduce the ratio of thromboxane b2 to 6-keto prostaglandin f1α, leading to an improvement in our blood coagulation system . As a side note Tanshinoate IIA has also been found to act as a powerful anti-cancer by its ability to trigger apoptosis through P53 activation among other mechanisms . Additionally it has been shown to improve renal dysfunction by its interaction with angiotensin II, transforming growth factor β1 and collagen IV, as well as inducing apoptosis of hepatic stellate cells, reducing the effects of liver fibrosis, in rats . Overall Tanshinone II is seen to be a very potent natural cardioprotective with its ability to dilate coronary arteries, lower blood pressure and lipids, protect from ischemic injury, act as a anti-inflammatory, antiplatelet, antithrombotic, antiarrhythmic, anticoagulant, and reverse myocardial hypertrophy .
Ginseng is widely known for it restorative and healing properties. Panax Notoginseng has specifically been shown to have protective effects against cardiovascular disease, liver fibrosis and hepatotoxicity . Primarily through the effects of its various constituents that have been shown to provide antioxidation, decreased platelet adhesion, vasomotor control and improved lipid profiles. Additionally it has been shown to enhance physical performance during endurance activity in humans . This is primarily due to high levels of radical scavenging antioxidants and saponins that exhibit anti-inflammatory, vasodilating, anti-fatigue and the ability to act as a central nervous system stimulant . Panax notoginseng may also be able to provide cardiovascular protection through various pharmacological mechanisms that improve microcirculation, regulate lipids, reducing arrhythmia, and has been shown to normalize blood pressure by restoring it to normal levels in individuals with both high and low blood pressure . It has also shown to act as an antioxidant against atherogenesis . For spanions of Panax Notoginseng have been found to have antihyperlipidemic and atherosclerotic effects . These atherosclerotic effects are especially prominent when used in conjunction with Salvia Miltiorrhiza . Additionally It has also been shown to be beneficial in protecting against tissue damage, have antihypertensive effects and may be a novel therapy for heart failure, as well as acting as a powerful antioxidant by its ability to significantly increase both superoxide dismutase and glutathione peroxidase activity . By protecting cardiac muscle from ischemic and reperfusion injuries . Research has also shown notoginseng to inhibit platelet aggregation and have preventive effects for thrombosis in vivo .
Pueraria Lobata has been used in conjunction with Salviae miltiorrhizae traditionally. Studies have shown that the two herbs work synergistically and additively, leading to improved vascular function in coronary patients . Studies have demonstrated it to have anti-hypertension, anti-thrombosis, cholesterol lowering effects, and when used in conjunction with Salvia Miltiorrhiza is able to lower low-density lipoprotein and total cholesterol levels in human subjects . Additionally, Puerinin has been shown to have protective effects against liver fibrosis, providing reduced oxidation, inflammation, of the liver, as well as protective effects against liver fibrosis and blood pressure .
Natural Borneol is utilized to increase the pharmacokinetic effects of the formula, particullary offering a significant 1.3-1.6 fold increase in effects of the saponins of notoginseng, as well as increasing the intestinal absorption and effects of the constituents of Salvia Miltiorrhiza . In addition it helps improve oral bioavailability for the entire herbal formula .
Whats the recommended dosage for Cordis?
As a dietary supplement, take two (2) capsules twice daily with a small meal consisting of healthy fats.
Research and References:
 Beckerman, J. (2014, May 26).
Atherosclerosis: Causes, Symptoms, Tests, and Treatment – WebMD.
Retrieved November 19, 2014, from http://www.webmd.com/heart-disease/what-is-atherosclerosis
 Lam, F.F., Yeung, J.H., Kwan, Y.W., Chan, K.M., Or, P.M., 2006.
Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary
artery by inhibition of calcium channels.
European Journal of Pharmacology 553, 240–245.
 Chan, P., Liu, I.M., Li, Y.X., Yu, W.J., Cheng, J.T., 2009.
Antihypertension induced by tanshinone IIA isolated from the roots of Salvia miltiorrhiza. Evidence-based Complementary and Alternative Medicine.
 Zuchang Li, Ling Zhu, Bin Huang.
Effects of purified herbal extract of Salvia miltiorrhiza on lipid profile in hyperlipidemic patients.
March 2009 Vol 6 No 2 99
 Ji W, Gong BQ.
Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats.
J Ethnopharmacol 2008; 119:291-8.
 Liu YL, Liu GT.
Inhibition of human low-density lipoprotein oxidation by salvianolic acid-A.
Yao Xue Xue Bao(Acta pharom) 2002;37:81-5. (in Chinese).
 Lynn EG, Vazhappilly R, Au-Yeung KK, et al.
Magnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation.
Life Sci 2001;68:903-12.
 Niu XL, Ichimori K, Yang X, Hirota Y, Hoshiai K, Li M, Nakazawa H
Tanshinone II-A inhibits low density lipoprotein oxidation in vitro.
Free Radic Res. 2000 Sep;33(3):305-12.
 Hui Pang mail, Bing Han, Tao Yu, Zhen Peng
The Complex Regulation of Tanshinone IIA in Rats with Hypertension-Induced Left Ventricular Hypertrophy
Published: March 19, 2014 DOI: 10.1371/journal.pone.0092216
 Huang, K.J., H. Wang, W.Z. Xie and H.S. Zhang.
Investigation of the effect of tanshinone IIA on nitric oxide production in human vascular endothelial cells by fluorescence imaging.
Spectrochim. Acta A. Mol. Biomol. Spectrosc. 68:1180-1186, 2007.
 Xu S, Liu P (2013)
Tanshinone IIA: new perspectives for old remedies.
Expert Opin Ther Pat 23: 149–153 doi:10.1517/13543776.2013.743995. PubMed: 23231009.
 Yang P, Jia YH, Li J, Li LJ, Zhou FH (2010)
Study of anti-myocardial cell oxidative stress action and effect of tanshinone IIA on prohibitin expression.
J Tradit Chin Med 30: 259–264. PubMed: 21287782.
 Chan P, Liu JC, Lin LJ, Chen PY, Cheng TH, et al. (2011)
Tanshinone IIA Inhibits Angiotensin II-Induced Cell Proliferation in Rat Cardiac Fibroblasts. Am J Chin Med 39: 381–394 doi:10.1142/S0192415X11008890. PubMed: 21476213.
 Zhang Y, Zhang L, Chu W, Wang B, Zhang J, et al. (2010)
Tanshinone IIA Inhibits miR-1 Expression through p38 MAPK Signal Pathway in Post-infarction Rat Cardiomyocytes.
Cell Physiol Biochem 26: 991–998 doi:10.1159/000324012. PubMed: 21220930.
 Tan X, Li J, Wang X, Chen N, Cai B et al.. (2011)
Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Cal-cineurin/Nfatc3 Pathway. Int J Biol Sci 7: 383–389. PubMed: 21494433.
 ]D.G. Kang, H. Oh, H.T. Chung, H.S. Lee
Inhibition of angiotensin converting enzyme by lithospermic acid B isolated from radix Salviae miltiorrhiza bunge
Phytother Res, 17 (8) (2003), pp. 917–920
 Journal of Geriatric Cardiology March 2009 Vol 6 No 2
 Z. Zhang, et al.
Tanshinone IIA triggers p53 responses and apoptosis by RNA polymerase II upon DNA minor groove binding
Biochem. Pharmacol., 78 (2009), pp. 1316–1322
Yong Zhang 1, Peixin Jiang 1, Min Ye 2, Sung-Hoon Kim 3, Cheng Jiang 1,* and Junxuan Lü
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
Int. J. Mol. Sci. 2012, 13, 13621-13666;
 Y.M. Ahn, S.K. Kim, S.H. Lee, S.Y. Ahn, S.W. Kang, J.H. Chung, S.D. Kim, B.C. Lee
Renoprotective effect of Tanshinone IIA an active component of Salvia miltiorrhiza, on rats with chronic kidney disease
Phytother. Res., 24 (2010), pp. 1886–1892
 X.H. Che, E.J. Park, Y.Z. Zhao, W.H. Kim, D.H. Sohn
Tanshinone II A induces apoptosis and S phase cell cycle arrest in activated rat hepatic stellate cells
Basic Clin. Pharmacol. Toxicol., 106 (2010), pp. 30–37
 M. T. Zhang, Y. H. Qian, and A. Q. Tang,
“Research progress of pharmacologic actions of Tanshinone II A,”
Medical Recapitulate, vol. 16, no. 17, pp. 2661–2664, 2010.
 Q. Shang, H. Xu, and L. Huang,
“Tanshinone IIA: a promising natural cardioprotective agent,”
Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 716459, 7 pages, 2012.View at Publisher · View at Google Scholar · View at Scopus
 Z. Yang and M. Qiu,
“Cardiovascular effects of tanshinone II A and its mechanism research progress,”
Chinese Journal of Arteriosclerosis, vol. 19, no. 4, pp. 372–374, 2011.
 X. H. Chen,
“Clinical analysis of tan II A on the cardiovascular effects,”
Medical Information, vol. 24, no. 7, p. 4207, 2011.
 H. L. Chen,
“Research progress of Sodium Tanshinon II A sulfonate injection in the treatment of cardiovascular diseases,”
Guide of China Medicine, vol. 11, no. 12, pp. 459–461, 2013.
W.H. Park, S.K. Lee, C.H. Kim
A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats
Life Science, 76 (2005), pp. 1675–1690
 C.F. Lin, K.L. Wang, R.S.C. Wu, T.C. Huang, C.F. Liu
Protection by hot water extract of Panax notoginseng on chronic ethanol-induced hepatotoxicity
Phytotherapy Research, 17 (2003), pp. 1119–1122
 L.X. Li, Z.C. Wang, Z.H. Huang, Y.M. Zhang, J.X. Wei
Effects of Panax notoginseng saponins on acute cerebral ischemia
Chinese Pharamcology Bulletin, 7 (1991), pp. 56–59
 Liang MT1, Podolka TD, Chuang WJ.
Panax notoginseng supplementation enhances physical performance during endurance exercise.
J Strength Cond Res. 2005 Feb;19(1):108-14.
 Chang Ho Lee , Jong-Hoon Kim
A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases
J Ginseng Res 38 (2014) 161e166
 Q.F. Xu, X.L. Fang, D.F. Chen
Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats
J. Ethnopharmacol., 84 (2003), pp. 187–192
 Jeon BH, Kim CS, Park KS, Lee JW, Park JB, Kim KJ, Kim SH, Chang SJ, Nam KY.
Effect of Korea red ginseng on the blood pressure in conscious hypertensive rats.
Gen Pharmacol 2000;35:135e41.
 Shin W, Yoon J, Oh GT, Ryoo S.
Korean red ginseng inhibits arginase and contributes to endothelium-dependent vasorelaxation through endothelial nitric oxide synthase coupling.
J Ginseng Res 2013;37:64e73.
 M. Yan,
Report of isosorbide 5-mononitrate and panax notoginseng for angina pectoris
Gansu Journal of Traditional Chinese Medicine, vol. 18, no. 1, p. 28, 2005.
 P. Chan, G. N. Thomas, and B. Tomlinson
Protective effects of trilinolein extracted from Panax notoginseng against cardiovascular disease
Acta Pharmacologica Sinica, vol. 23, no. 12, pp. 1157–1162, 2002
 Zhang YG, Zhang HG, Zhang GY, Fan JS, Li XH, Liu YH, Li SH, Lian XM, Tang Z.
Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the
blood lipid profile and an anti-inflammatory action.
Clin Exp Pharmacol Physiol 2008;35:1238e44.
 Liu G, Wang B, Zhang J, Jiang H, Liu F.
Total Panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: role of downregulation of CD40 and MMP-9 expression.
J Ethnopharmacol 2009;126:350e4.
 Jia Y, Li ZY, Zhang HG, Li HB, Liu Y, Li XH.
Panax notoginseng saponins decrease cholesterol ester via up-regulating ATP-binding cassette transporter A1 in foam cells.
J Ethnopharmacol 2010;132:297e302.
 Kwak YS, Kyung JS, Kim JS, Cho JY, Rhee MH.
Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng.
Biol Pharm Bull 2010;33:468e72.
 Baek EB, Yoo HY, Park SJ, Chung YS, Hong EK, Kim SJ.
Inhibition of arterial myogenic responses by a mixed aqueous extract of salvia miltiorrhiza and Panax notoginseng (PASEL) showing antihypertensive effects.
Korean J Physiol Pharmacol 2009;13:287-293.
 Li J, Ichikawa T, Jin Y, Hofseth LJ, Nagarkatti P, Nagarkatti M, Windust A, Cui T.
An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions
J Ethnopharmacol 2010;130:222e30.
 Sohn SH, Kim SK, Kim YO, Kim HD, Shin YS, Yang SO, Kim SY, Lee SW.
A comparison of antioxidant activity of Korean White and Red Ginsengs on
H2O2-induced oxidative stress in HepG2 hepatoma cells.
J Ginseng Res 2013;37:442e50.
 Vuksan V, Stavro M, Woo M, Leiter LA, Sung MK, Sievenpiper JL.
Korean red ginseng (Panax ginseng) can lower blood pressure in individuals with hypertension:
a randomized controlled trial.
In: Proceedings of the 9th
 Wagner HN, Liu X.
The international textbook of cardiology.
New York: Pergamon Press; 1987.
 Kim TH, Lee SM.
The effects of ginseng total saponin, panaxadiol and panaxatriol on ischemia/reperfusion injury in isolated rat heart.
Food Chem Toxicol 2010;48:1516e20.
 Tamura Y.
Effects of Korean red ginseng on eicosanoid biosynthesis in platelets
and vascular smooth muscle cells.
In: Proceedings of the 6th International Ginseng Symposium. Seoul: Korean Society of Ginseng; 1993. p. 28–9.
 Dong-Ha Lee DH, Cho HJ, Kim HH, Rhee MH, Ryu JH, Park JH.
Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser157 phosphorylation on thrombin-induced platelet aggregation.
J Ginseng Res 2013;37:176e86.
 Jin YR, Yu JY, Lee JJ, You SH, Chung JH, Noh JY, Im JH, Han XH, Kim TJ, Shin KS,
Antithrombotic and antiplatelet activities of Korean red ginseng extract.
Basic Clin Pharmacol Toxicol 2007;100:170e5.
 Tam, W.Y., Chook, P., Qiao, M., Chan, L.T., Chan, T.Y., Poon, Y.K., Fung, K.P., Leung,
P.C., Woo, K.S., 2009.
The efficacy and tolerability of adjunctive alternative herbal
medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure
in coronary patients.
Journal of Alternative and Complementary Medicine 15, 415–421.
 David Wing-Shing Cheung, Chi-ManKoon, Chun-Fai Ng, Ping-Chung Leung,
Kwok-Pui Fung, SimonKar-SingPoon, ClaraBik-SanLau,
The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibit
A study of the combination effects of the 2-herb formula Journal of Ethnopharmacology 143(2012)859–866
 Xia Wang, Xue Xu, Weiyang Tao, Yan Li, Yonghua Wang, and Ling Yang
A Systems Biology Approach to Uncovering Pharmacological Synergy in Herbal Medicines with
Applications to Cardiovascular Disease
Evidence-Based Complementary and Alternative Medicine Volume 2012, Article ID 519031, 15 pages doi:10.1155/2012/519031
 Kwok T, Leung PC, Lam C, Ho S, Wong CK, Cheng KF, Chook P.
A randomized placebo controlled trial of an innovative herbal formula in the prevention of atherosclerosis in postmenopausal women with borderline hypercholesterolemia.
Complement Ther Med. 2014 Jun; 22(3):473-80. Epub 2014 Apr 6.
 Sun, X.H., Ding, J.P., Li, H., Pan, N., Gan, L., Yang, X.L., Xu, H.B., 2007.
Activation of large conductance calcium-activated potassium channels by puerarin: the underlying mechanism of puerarin-mediated vasodilation.
Journal of Pharmacology andExperimental Therapeutics 323, 391–397.
 Choo, M.K., Park, E.K., Yoon, H.K., Kim, D.H., 2002.
Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora.
Biological and Pharmaceutical Bulletin 25, 1328–1332.
 Yan, L.P., Chan, S.W., Chan, A.S., Chen, S.L., Ma, X.J., Xu, H.X., 2006.
Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide
synthase expression in diet-induced hypercholesterolemic rats.
Life Sciences 79, 324–330.
 Sieveking, Daniel P. ; Woo, Kam-Sang ; Fung, Kwok P. ; Lundman, Pia ; Nakhla, Shirley ; Celermajer, David S.
Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro
International Journal of Cardiology, 2005, Vol.105(1), pp.40-45
 Song, X.P., Chen, P.P., Chai, X.S., Zhongguo Yao Li Xue
Effects of puerarin on blood pressure and
plasma renin activity in spontaneously hypertensive rats.
Bao 9, 55–58. 1988.
 Peng J, et al.
Puerarin Ameliorates Experimental Alcoholic Liver Injury by Inhibition of Endotoxin Gut-leakage, kupffer Cell Activation and Lipopolysaccharide Receptors Expression.
J Pharmacol Exp Ther. (2012)
 Zhang S, Ji G, Liu J.
Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin.
J Nutr Biochem. (2006)
 Li R, et al.
Puerarin mediates hepatoprotection against CCl(4)-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function.
Food Chem Toxicol. (2013)
 SH Yang, K Zhang, X Lin, .
Pharmacokinetic comparisons of single herb extract of Fufang Danshen preparation with different combinations of its constituent herbs in rats.Journal of Pharmaceutical and Biomedical. Analysis Volumes 67–68, August–September 2012, Pages 77–85
 Lai XJ1, Zhang L, Li JS, Liu HQ, Liu XH, Di LQ, Cai BC, Chen LH.
Comparative pharmacokinetic and bioavailability studies of three salvianolic acids after the administration of Salviae miltiorrhizae alone or with synthetical borneol in rats.
Fitoterapia. 2011 Sep;82(6):883-8. doi: 10.1016/j.fitote.2011.04.015. Epub 2011 May 4.
 Ren-Zhong W1, Yan-Yan X, Yan-Ping L, Mao-Jin Z, Chang-Xiao L.
Enhancing effects of different dosages of borneol on pharmacokinetics of salvanic acid B after oral administration to rats.
J Asian Nat Prod Res. 2012;14(6):538-44. doi: 10.1080/10286020.2012.680439.
 J.P. Dai, J. Chen, Y.F. Bei, B.X. Han, S. Wang
Influence of borneol on primary mice oral fibroblasts: a penetration enhancer may be used in oral submucous fibrosis.
J. Oral. Pathol. Med., 38 (2009), pp. 276–281
This product is intended for healthy adults, 18 and older. Consult your physician before using this or any dietary supplement. Do not use this product if you have any pre-existing medical conditions, are pregnant, breast feeding, elderly, chronically ill, or taking any prescription or over-the-counter medication. Discontinue use and contact your doctor if you experience dizziness, headache, nausea, or heart palpitations. KEEP OUT OF REACH OF CHILDREN. End user assumes all risk from handling, storage, and use of this product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.